Rationality Of Antibiotic Use In Lower Respiratory Tract Infections In Paediatric Patients
International Journal of Drug Delivery Technology · 14.05.2026 · 16 (43s)
DOI: 10.25258/ijddt.16.43s.136 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 14.05.2026. Verfasst von NITHYA S und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Lower respiratory tract infections (LRTI) are infections that affect the lungs, bronchi and bronchioles. LRTI is the predominant cause of mortality and morbidity in children below 5 years of age. The motive of the study is to assess the rationality of antibiotic use in LRTI in pediatric patients. The study was carried out for 6 months in which 200 pediatric patients were selected on the basis of inclusion and exclusion criteria. This study encompasses 53.5% of male and 46.5% female manifesting that LRTI is more common in male than female. This difference may include anatomical and physiological variations in the respiratory system, with male children often having narrower airways, making them more susceptible to airway obstruction during infections. In addition, immunologic factors such asthe difference in the response of the immune system and hormonal factors can also contribute to the observed trend. The study of the pattern of antibiotic prescriptions showed that there was a predominance of the prescription of Ceftriaxone, which was used as monotherapy in 146 cases (73%). The second type of regimen was the combination of antibiotics, with the first being the combination of Ceftriaxone with Azithromycin in 13 cases (6.5%), followed by the combination of Ceftriaxone with Amikacin in 5 cases (2.5%), the combination of Ceftriaxone with Amoxicillin in 3 cases (1.5%), and the combination of Ceftriaxone with Doxycycline in 3 cases (1.5%). A few cases were of the regimen of Amikacin with Azithromycin (2 cases or 1%), Azithromycin with Amoxicillin (1 case or 0.5%), and the regimen where the patient was not given antibiotics at all in 27 cases (13.5%).The overwhelming reliance on Ceftriaxone highlights its status as the empirical antibiotic of choice in paediatric LRTIs in this setting, likely due to its broad-spectrum activity, favourable safety profile, and convenient dosing schedule.
Zitieren
APA
S, N., R, S., S, N., M, R., R, R., B, A., & J, K. (2026). Rationality Of Antibiotic Use In Lower Respiratory Tract Infections In Paediatric Patients. International Journal of Drug Delivery Technology, 16(43s). https://doi.org/10.25258/ijddt.16.43s.136
Vancouver
S N, R S, S N, M R, R R, B A, et al. Rationality Of Antibiotic Use In Lower Respiratory Tract Infections In Paediatric Patients. International Journal of Drug Delivery Technology. 2026;16(43s). doi:10.25258/ijddt.16.43s.136
BibTeX
@article{S2026,
author = {S, NITHYA and R, SHANKAR and S, NISHA and M, RAMYA and R, RANJITHA and B, ARUL and J, KARISHMA},
title = {Rationality Of Antibiotic Use In Lower Respiratory Tract Infections In Paediatric Patients},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {43s},
doi = {10.25258/ijddt.16.43s.136}
}
EUVIMED